EP 0436611 A4 19920311 - COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING
Title (en)
COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING
Publication
Application
Priority
AU PJ067588 A 19880928
Abstract (en)
[origin: WO9006102A1] The present invention provides a method for reducing or preventing collagen cross-linking in skin and/or damage to skin cell DNA. The method comprises treating the skin with a composition including an antioxidant compound. The antioxidant compound is selected from the group consisting of carnosine, homocarnosine, anserine, 3-methyl-L-histidine, L-alanyl-L-tyrosine, acyl homocarnosine, acetyl carnosine, iodo carnosine, di-iodo carnosine, anserine nitrate, carbenoxylone carnosine, analogues thereof and combinations thereof. The antioxidant compounds of choice are carnosine and homocarnasine with preference for carnosine.
IPC 1-7
IPC 8 full level
A61K 8/49 (2006.01); A61K 8/64 (2006.01); A61K 31/415 (2006.01); A61K 33/04 (2006.01); A61K 38/00 (2006.01); A61K 38/04 (2006.01); A61Q 17/04 (2006.01); A61Q 19/08 (2006.01)
CPC (source: EP)
A61K 8/4946 (2013.01); A61K 8/64 (2013.01); A61K 31/415 (2013.01); A61K 33/04 (2013.01); A61K 38/04 (2013.01); A61Q 17/04 (2013.01); A61Q 19/08 (2013.01); A61K 2800/522 (2013.01)
C-Set (source: EP)
Citation (search report)
- [X] FR 2609393 A1 19880715 - SEROBIOLOGIQUES LAB SA [FR]
- See references of WO 9006102A1
Designated contracting state (EPC)
DE FR GB IT
DOCDB simple family (publication)
WO 9006102 A1 19900614; EP 0436611 A1 19910717; EP 0436611 A4 19920311
DOCDB simple family (application)
AU 8900422 W 19890928; EP 89910999 A 19890928